In this session, the work of the Neuroimmunology Group at RSU will be presented, with a special focus on how translational research is reshaping understanding and management of Myasthenia Gravis (MG) — a rare autoimmune neuromuscular disease.
The discussion will be divided into two parts. The first part will provide an overview of current research directions in neuroimmunology, highlighting innovative approaches in immune profiling, biomarker discovery, and the integration of advanced technologies such as proteomics (OLINK), flow cytometry, and genetic analysis.
The second part will focus on how international collaborations and cutting-edge diagnostics are paving the way for personalized medicine in MG and other rare neurological diseases. I will share insights from joint projects with leading institutions across Europe and Israel, emphasizing how these partnerships contribute to advancing patient care and scientific knowledge.
Target audience: Students, researchers, public health experts, health policy makers and professionals |
| |
| 15.30–16.30 | Presentation | |
| 16.30–17.00 | Discussion and coffee | |
What you'll learn
- How immune dysregulation, interferons, autoantibodies, and viral reactivation contribute to MG pathogenesis.
- The role of different diagnostic tools in identifying biomarkers for disease progression and treatment response.
- How translational research bridges clinical practice and laboratory science to improve outcomes for patients with rare neurological diseases.
- Opportunities for researchers, clinicians, and industry partners to engage in collaborative neuroimmunology projects at RSU.
Why this matters
Autoimmune diseases like Myasthenia Gravis pose significant diagnostic and therapeutic challenges due to their complexity and variability. Advancing precision medicine through biomarker research and international collaboration is essential to deliver targeted, effective treatments and improve patients' quality of life.
Future directions
Our group is committed to:
- Expanding RSU’s capacity in neuroimmunology and neurological disease research.
- Developing RSU as an active node in European research networks focused on MG and neuroimmunology.
- Engaging young researchers and clinicians in multidisciplinary projects.
- Strengthening partnerships with industry for the development of innovative diagnostic tools.
Takeaway
Precision medicine in neuroimmunology is not a distant goal — it is being built today through collaborative research, advanced diagnostics, and a deeper understanding of immune mechanisms in diseases like Myasthenia Gravis.
About the lecturer
Assoc. Prof. Dr. Viktorija Ķēniņa is Head of the Rare Neurological Disease Centre at Pauls Stradiņš Clinical University Hospital and leads the Neuroimmunology Research Group at Rīga Stradiņš University. Her research focuses on immune-mediated neurological diseases, particularly Myasthenia Gravis, exploring the complex interplay between immune dysregulation, chronic viral infections, and neuroinflammation.
Dr. Ķēniņa coordinates multiple international collaborations across Finland, Sweden, Estonia, Germany, and Israel, working on biomarker discovery, precision diagnostics, and translational neuroimmunology. She is passionate about fostering young researchers and strengthening RSU's presence in European scientific networks.
Location
Tā kā Rīgas Stradiņa universitāte ir publiska iestāde, pasākuma laikā jūs varat tikt fotografēts un/ vai filmēts. Fotogrāfijas un video var tikt publicēts universitātes mājaslapā, sociālajos medijos u. tml. Vairāk par savām tiesībām un iespēju iebilst pret šādu datu apstrādi varat uzzināt RSU Privātuma politikā. Ja iebilstat pret personas datu apstrādi, lūdzam par to informēt, rakstot uz rsu
rsu[pnkts]lv (rsu[at]rsu[dot]lv).
As Rīga Stradiņš University (RSU) is a public institution you could be photographed and/or filmed during the event. Your personal data might be used to further the interests of RSU, e.g. for marketing or communication activities (incl. social media coverage). Read more about your rights see the RSU Privacy Policy. Should you have any objections to your personal data being processed please inform us via e-mail at rsursu[pnkts]lv (rsu[at]rsu[dot]lv).
